Last updated: November 2026
Clinical trial billing compliance is the set of written procedures a hospital or research site uses to decide which items and services in a trial Medicare covers, and to code each claim to match that decision. The Medicare texts behind it are National Coverage Determination (NCD) 310.1, Routine Costs in Clinical Trials, and Chapter 32, section 69 of the Medicare Claims Processing Manual. Integral Healthcare Solutions (IHS) tests your coverage analysis and claim-coding procedures against those texts and drafts the missing procedures for your compliance staff and counsel to approve; your site decides which trials qualify and submits its own claims.
What is clinical trial billing compliance under Medicare?
The Medicare Coverage Database page for NCD 310.1, Routine Costs in Clinical Trials, version 3 (opened November 5, 2026) lists version 3 as in effect from May 27, 2024.
For items and services furnished on or after July 9, 2007, Medicare covers the routine costs of qualifying clinical trials, as the NCD defines them, and reasonable and necessary items and services used to diagnose and treat complications arising from participation in all clinical trials. All other Medicare rules apply.
Routine costs include all items and services otherwise generally available to Medicare beneficiaries (a benefit category exists, it is not statutorily excluded, and there is no national non-coverage decision) provided in either the experimental or the control arm of a trial, except:
- The investigational item or service itself, unless it is otherwise covered outside of the clinical trial.
- Items and services provided solely to satisfy data collection and analysis needs that are not used in the direct clinical management of the patient.
- Items and services customarily provided by the research sponsors free of charge for any enrollee in the trial.
Routine costs can include conventional care, administering the investigational intervention, clinically appropriate monitoring, preventing complications, and reasonable and necessary care arising from the intervention. For non-covered items, Medicare covers treatment of resulting complications and unrelated reasonable and necessary care. If national non-coverage is the reason and the item is the focus of a qualifying trial, routine costs are covered but the item is not. The NCD preserves coverage that may exist under local coverage determinations or the Category B device rules it cites.
What makes a clinical trial qualifying under NCD 310.1?
A trial must meet three requirements, which the NCD says are not enough by themselves. It must evaluate an item or service in a Medicare benefit category and not statutorily excluded; it must not be designed exclusively to test toxicity or disease pathophysiology and must have therapeutic intent; and a trial of a therapeutic intervention must enroll patients with diagnosed disease rather than healthy volunteers, though a diagnostic trial may enroll healthy patients in order to have a proper control group.
The seven desirable characteristics concern potential improvement in participants’ health outcomes; scientific support, or clarifying outcomes of interventions already in common use; no unjustified duplication; appropriate design; a credible, capable sponsor; compliance with Federal human-subject protections; and scientific integrity. Some trials are presumed to meet them and are automatically qualified: trials funded by NIH, CDC, AHRQ, CMS, DOD or VA; trials supported by centers or cooperative groups they fund; and trials conducted under an investigational new drug application reviewed by FDA. Drug trials exempt from an IND under 21 CFR 312.2(b)(1) are deemed automatically qualified until the qualifying criteria are developed and the certification process is in place. At that point their principal investigators must certify the criteria are met to maintain routine-cost coverage; certification affects future status, not earlier deemed status.
Medicare covers the routine costs of qualifying trials that are deemed automatically qualified, have certified that they meet the qualifying criteria, or are required through the NCD process, unless CMS’s Chief Clinical Officer subsequently finds that a trial does not meet the criteria or jeopardizes the safety or welfare of Medicare beneficiaries. The NCD describes certification and a Medicare clinical trials registry as under development; this page does not say how either operates today. Under the NCD, investigators of automatically qualified trials need not certify qualification, but must enroll those trials in the Medicare registry once it is established. If CMS finds an investigator misrepresented qualification to obtain coverage, routine-cost coverage is denied and beneficiaries are held harmless.
How does Medicare require a clinical trial claim to be coded?
Section 69 of the Medicare Claims Processing Manual, Chapter 32, Billing Requirements for Special Services (Rev. 13551, issued December 19, 2025; section 69.6 effective January 21, 2026; page opened November 5, 2026) sets the claim elements.
| Claim element | What section 69 says |
|---|---|
| Clinical trial number | For dates of service on or after January 1, 2014, reporting the trial number is mandatory for clinical trials, studies, registries and coverage with evidence development. Section 69.6 also requires it on institutional clinical trial claims received after April 1, 2008, regardless of service date. Use the eight digits following NCT on ClinicalTrials.gov: electronic claims use Loop 2300 REF02 (REF01=P4); paper CMS-1500 uses Field 19 with a CT prefix; paper CMS-1450 uses value code D4. Missing numbers make practitioner claims unprocessable and institutional claims returnable to the provider. |
| Z00.6 and condition code 30 | Practitioner claims should include ICD-10 code Z00.6 in the primary or secondary position, and a claim with modifier Q1 is returned as unprocessable without it. Institutional claims must report Z00.6 and condition code 30; on inpatient claims that applies whether or not all services relate to the trial. |
| Modifiers Q0 and Q1 | Q0 identifies investigational clinical services in an approved research study; a Category B IDE code also requires the IDE number on the claim. Q1 identifies medically necessary routine patient care or treatment of complications arising from participation in a Medicare covered trial; billed with Z00.6, it serves as the provider’s attestation that the service meets the coverage criteria. Q1 cannot be used for items supplied solely for data collection and analysis without use in clinical management, or for items excluded by statute or lacking a Medicare benefit category. On outpatient clinical trial claims, for service dates from January 1, 2008, investigational lines carry Q0 and routine lines Q1. Inpatient claims do not report HCPCS codes, so Q0/Q1 requirements do not apply. |
| Separate lines and sponsor-paid items | Trial and non-trial services go on separate lines when both appear on one claim. Items provided free of charge by research sponsors generally may not be billed to Medicare. If a provider must show them to receive payment for covered routine costs, it submits those charges as non-covered at entry, while assuring the beneficiary is not held liable. |
Who needs a billing compliance program and what triggers it?
IHS suggests reviewing billing procedures in these situations; they are proposed triggers, not triggers listed in the two CMS texts:
- The protocol, sponsor contract and budget describe the same service differently, and no one maps each to a billing decision.
- An internal review, an audit or a payer question has raised a possible overpayment.
How does IHS help?
IHS tests how your site reaches and records a billing decision against NCD 310.1 and section 69, then drafts what is missing.
- Gap assessment of your coverage analysis and claim-coding procedures against the NCD and section 69.
- A coverage analysis procedure saying who reads the protocol, contract and budget and how each item’s result is recorded.
- A billing grid template recording whether each protocol item goes to Medicare, the sponsor or neither. A grid is IHS practice; these two CMS texts do not expressly require one.
- Document and evidence mapping, a second-review workflow, a training outline and a mock review of sample billing decisions.
IHS drafts procedures and any clinical content for your clinicians, compliance staff and counsel to approve. Your site supplies protocols, sponsor contracts, budgets, billing procedures, charge descriptions and its own determinations of which trials qualify. IHS does not decide whether a trial qualifies, gives no coverage opinion on any trial and does not contact CMS or a Medicare contractor.
What to have ready
IHS suggests these records; the linked texts set the rules, not these formats.
- A site-approved qualification assessment (IHS practice): NCD 310.1 v3, sections A and B.
- An item-by-item coverage analysis (IHS practice): NCD 310.1 v3, routine costs.
- Flags for investigational items and data-only items unused in direct clinical management, recording any coverage outside the trial: NCD 310.1 v3.
- Sponsor-free items and conditional noncovered-charge handling that protects beneficiaries: Claims Processing Manual Ch. 32, section 69.5, Rev. 2955.
- A claim-type coding procedure (IHS practice), including separate trial and nontrial lines when both appear on one claim: Claims Processing Manual Ch. 32, sections 69.5–69.6, Revs. 2955/13551.
- Medical records with trial name, sponsor and sponsor-assigned protocol number, available for requested medical review: Claims Processing Manual Ch. 32, section 69.3, Rev. 487.
If several are missing, bring the list to the free introductory call.
How does it compare with other approaches?
In house, the site performs coverage analysis and claim review. With IHS, IHS drafts procedures, a grid template and review steps, and the site supplies trial documents, approves the work and makes billing decisions.
What does it cost?
The CMS texts we reviewed list no fee schedule. IHS scopes each engagement after a free introductory call.
What this is not
- IHS is a consulting firm, not a law firm; this service provides neither legal advice nor a trial-specific coverage opinion, and fraud and abuse questions remain with counsel.
- This page does not establish current CMS certification or registry operations.
Frequently asked questions
What are routine costs under Medicare NCD 310.1?
Routine costs include otherwise available Medicare items and services in either trial arm, subject to benefit-category, statutory-exclusion and national-coverage rules, including the NCD’s special rule for an item subject to national non-coverage. Exceptions are the investigational item unless covered outside the trial; items solely for data collection and analysis without use in direct clinical management; and items sponsors customarily provide free to any enrollee.
What is a qualifying clinical trial?
NCD 310.1 describes three requirements plus qualification through automatic status, certification or the NCD process. Coverage is subject to a subsequent finding by CMS’s Chief Clinical Officer that the trial fails the criteria or jeopardizes beneficiaries’ safety or welfare. The NCD describes a registry under development; this page does not establish current certification or registry operations.
What is a coverage analysis?
IHS uses coverage analysis to mean a documented review of protocol items, sponsor funding and applicable Medicare coverage rules. The site’s authorized reviewers make the billing determinations; IHS drafts the review procedure.
What is a billing grid, and is it required?
A billing grid records the proposed payer for each protocol item. IHS offers it as a working tool; neither NCD 310.1 nor Chapter 32, section 69 expressly requires a grid.
Which codes does a Medicare claim for a trial item need?
Section 69.6 specifies the eight-digit trial number and Z00.6, with condition code 30 on institutional clinical trial claims. Q0 identifies investigational lines and Q1 routine lines on outpatient clinical trial claims; inpatient claims do not use them. The table above lists the claim fields; NCT is the registry display prefix, not the claim-field prefix.
How do the protocol and the sponsor contract affect billing?
The protocol lists what is done, and the contract and budget say what the sponsor pays for. The NCD excludes items and services sponsors customarily provide free to any enrollee in the trial, so read the documents together.
Who should own the program, and how are discrepancies handled?
Neither CMS text assigns an owner. IHS suggests one owner and a second reviewer, and the procedure should say who reviews a claim that does not match the grid.
Does the program guarantee audit outcomes?
No. A written program shows how the site reaches billing decisions. It promises no result in an audit.